Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
17.03.25
/
50%
€35.20
Target price
17.03.26
€105.64
Performance (%)
-46.59%
End price
18.03.26
€18.80
Summary
This prediction ended on 18.03.26 with a price of €18.80. Massive losses of -46.59% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.073% | 2.073% | -33.893% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Piper Sandler from $140.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
13.01.25
13.01.25
€137.24
13.01.26
13.01.26
-50.00%
14.01.26
14.01.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€30.80
25.10.23
25.10.23
€122.98
25.10.24
25.10.24
61.04%
26.10.24
26.10.24